Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 24 for “"Pharmacogenetic Testing"”.
-
HEALTH ECONOMICS OF PHARMACOGENETIC TESTING
… FACTORS HAVE BEEN WELL ESTABLISHED, ADOPTION OF PHARMACOGENETIC TESTING TO REDUCE SJS RISK IN CLINICAL CARE HAS BEEN SLOW. I CONDUCT HEALTH ECONOMIC EVALUATIONS TO INFORM CLINICAL AND REGULATORY DECISION MAKING ON WHETHER PHARMACOGENETIC TESTING SHOULD BE DONE TO REDUCE THE RISK OF SJS IN …
-
Payer Perspectives On Preemptive Pharmacogenetic Testing
Purpose: As preemptive pharmacogenetics expands in the academic healthcare setting, further study is needed to assess the views of additional stakeholders in the marketplace on this technology and the barriers and facilitators to their uptake. The purpose of this study is to investigate the …
-
Pharmacogenetic testing in outpatient mental health clinics
… health clinicians' perceived knowledge regarding pharmacogenetic testing; their attitude, receptivity towards, and confidence in pharmacogenetic testing; and how pharmacogenetic testing is being implemented to support decision making in outpatient clinics. This study was guided by Rogers' …
-
EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS
Pharmacogenetic testing has potential to transform healthcare, yet implementation strategies have been limited to major academic medical centers serving metropolitan communities and large health systems. In contrast, rural, community-based health systems are slow to implement these advances, …
-
EQUITABLE PHARMACOGENETIC TESTING IMPLEMENTATION FOR RURAL AND UNDERSERVED POPULATIONS
Pharmacogenetic testing has potential to transform healthcare, yet implementation strategies have been limited to major academic medical centers serving metropolitan communities and large health systems. In contrast, rural, community-based health systems are slow to implement these advances, …
-
HIV genomics : trends in antiretroviral resistance and future directions for pharmacogenetic testing
… practices. Over the past two decades, genetic testing for HIV drug resistance has become an important tool for HIV care. Next generation massively parallel sequencing has proven to be a powerful sequencing tool rivaling the gold standard Sanger sequencing method, however it is not yet widely …
-
An assessment of barriers to nurse practitioners’ utilizing pharmacogenetic testing for depression
… is 60% (Alemi et al., 2021). Pharmacogenomic testing (PGT) is beneficial in disease management by determining individual genotype responses to specific medications. Incorporating PGT into routine care for depression can lessen the time it takes to reach disease remission as well as avoid any …
-
Depression Outcomes in Care Coordination, Primary Care and Psychiatry Patients After Pharmacogenetic Testing
… outcomes of patient activation before and after pharmacogenetic care in a coordinated care population. The process of pharmacogenetic care includes the patient’s acknowledgment of medication changes which are based on their genetic profile. This study will be framed by Dorothea Orem’s Self-Care …
-
Literacy, expectations, and satisfaction of psychiatric pharmacogenetic testing in youth receiving pharmacological treatment for a mental health condition
Background: Pharmacogenetic (PGx) testing uses a person’s DNA to inform prescribing. Despite established clinical benefits, patient literacy, expectations, and satisfaction with PGx testing is unclear, particularly in youth. This study assessed literacy, expectations, and satisfaction of PGx …
-
Perspectives on the Application of Pharmacogenomics in Patient Care
… in the clinical setting, through the use of pharmacogenetic testing, still has not gained widespread acceptance. This work describes multiple aspects of pharmacogenomics, which drive current research in this field. Chapter I is an introduction to pharmacogenomics. Regulatory agencies and …
-
Understanding Exposure to Pharmacogenetically Actionable Opioids in Primary Care
Pharmacogenetic testing has the potential to improve pain management through addressing wide interindividual variations in responses to pharmacogenetically actionable opioids, ultimately decreasing costly adverse drug effects and improving responses to these medications. A recent review of …
-
Overcoming barriers to the clinical implementation of pharmacogenomics : associations between UGT1A1*28 and irinotecan therapy clinical outcomes, and an exploration of the issues among hospital pharmacists
Pharmacogenetic testing aims to personalise drug therapy by prescribing medications according to an individual's genetic predisposition to drug efficacy and toxicity. More accurately targeting drug therapy to individuals most likely to respond and least likely to have adverse effects will benefit …
-
Personalized medicine: examining the current and future applications of pharmacogenetics and pharmacogenomics
… on the tumor genotype, the very definition of pharmacogenetic testing. More specifically, pharmacogenetics or pharmacogenomics is defined as variations in genes that can affect drug response. There has been great deal of research into pharmacogenetics and its potential fields for application. …
-
Investigating and identifying genetic predictors for cisplatin-induced hearing loss and anthracycline-induced cardiotoxicity
… enable development of a new CIHL predictive pharmacogenetic test that includes ACYP2 along with TPMT and recommend early pharmacogenetic testing to prevent CIHL. The additional genetic insight into ACT may also help improve the predictive ability of pharmacogenetic testing for ACT. This …
-
Implementation of pharmacogenetic risk prediction models in pediatric oncology
… Based on these clinical practice guidelines, pharmacogenetic risk prediction models that combined several genetic variants into one predicted outcome for anthracycline-induced cardiotoxicity and cisplatin-induced ototoxicity were developed using logistic regression. In this study, …
-
Personalizing Colorectal Cancer Care: Opportunities for Pharmacogenomics
… explores the opportunities for germline pharmacogenetic testing to inform chemotherapy and non-chemotherapy medication selection in a historical cohort of Americans with metastatic colorectal cancer and models the theoretical cost-effectiveness of implementing this approach.
-
Tools and Challenges for the Implementation of Next-Generation Sequencing in Clinical Pharmacogenetics
… an individual's response to therapeutic drugs (pharmacogenetics) is a unique area of research with significant translational impact for medicine. Known genetic variants with effects on important clinical phenotypes, including clopidogrel efficacy and warfarin maintenance dose, highlight the …
-
Human host and malaria parasite genome variations to susceptibility to malaria
… determine whether there are differences in the pharmacogenetic profiles when comparing populations residing in malaria endemic and non-endemic areas. Methodology: Genome-wide genotype datasets (n=13, 447) from four malaria endemic African populations, including Mali, Kenya, Gambia, and Malawi, …
-
Functional validation of UGT1A6 in anthracycline-induced cardiotoxicity
… of precision medicine can be achieved via pharmacogenetic testing prior to treatment onset thanks to the genomic revolution. It has allowed for large-scale genetic testing to be done relatively inexpensively resulting in specific genetic variants to be linked with a phenotype or disease of …
Page 1 of 2